DK0504799T3 - Blandede pyridin-2,4- og -2,5-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemidler på basis af disse forbindelser - Google Patents

Blandede pyridin-2,4- og -2,5-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemidler på basis af disse forbindelser

Info

Publication number
DK0504799T3
DK0504799T3 DK92104584.5T DK92104584T DK0504799T3 DK 0504799 T3 DK0504799 T3 DK 0504799T3 DK 92104584 T DK92104584 T DK 92104584T DK 0504799 T3 DK0504799 T3 DK 0504799T3
Authority
DK
Denmark
Prior art keywords
compounds
dicarboxylic acid
processes
preparation
acid diamides
Prior art date
Application number
DK92104584.5T
Other languages
Danish (da)
English (en)
Inventor
Ekkehard Dr Baader
Martin Dr Bickel
Manfred Dr Volz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0504799T3 publication Critical patent/DK0504799T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK92104584.5T 1991-03-18 1992-03-17 Blandede pyridin-2,4- og -2,5-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemidler på basis af disse forbindelser DK0504799T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4108824 1991-03-18

Publications (1)

Publication Number Publication Date
DK0504799T3 true DK0504799T3 (da) 1998-02-02

Family

ID=6427597

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92104584.5T DK0504799T3 (da) 1991-03-18 1992-03-17 Blandede pyridin-2,4- og -2,5-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemidler på basis af disse forbindelser

Country Status (22)

Country Link
EP (1) EP0504799B1 (ko)
JP (1) JP3121428B2 (ko)
KR (1) KR100243959B1 (ko)
AT (1) ATE154929T1 (ko)
AU (1) AU645668B2 (ko)
CA (1) CA2063177A1 (ko)
CZ (1) CZ282298B6 (ko)
DE (1) DE59208651D1 (ko)
DK (1) DK0504799T3 (ko)
ES (1) ES2104758T3 (ko)
FI (1) FI101701B1 (ko)
GR (1) GR3024309T3 (ko)
HR (1) HRP940835A2 (ko)
HU (1) HU217809B (ko)
IE (1) IE920843A1 (ko)
IL (1) IL101257A (ko)
MX (1) MX9201156A (ko)
NO (1) NO178859C (ko)
NZ (1) NZ241968A (ko)
TW (1) TW199147B (ko)
YU (1) YU48156B (ko)
ZA (1) ZA921945B (ko)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
ATE113036T1 (de) * 1988-08-04 1994-11-15 Hoechst Ag Verbessertes verfahren zur herstellung von n,n- bis(alkoxyalkyl)-pyridin -2,4- dicarbonsäurediamiden.
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3928144A1 (de) * 1989-08-25 1991-02-28 Hoechst Ag Zyklische pyridin-2,4- und -2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE3938805A1 (de) * 1989-11-23 1991-05-29 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4030999A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Also Published As

Publication number Publication date
HRP940835A2 (en) 1997-06-30
HUT62565A (en) 1993-05-28
ATE154929T1 (de) 1997-07-15
YU24692A (sh) 1994-06-24
JPH0586032A (ja) 1993-04-06
FI101701B (fi) 1998-08-14
IE920843A1 (en) 1992-09-23
CZ282298B6 (cs) 1997-06-11
NO178859B (no) 1996-03-11
DE59208651D1 (de) 1997-08-07
CS80392A3 (en) 1992-10-14
GR3024309T3 (en) 1997-10-31
AU645668B2 (en) 1994-01-20
KR920018051A (ko) 1992-10-21
NZ241968A (en) 1994-04-27
CA2063177A1 (en) 1992-09-19
AU1296792A (en) 1992-09-24
NO921025L (no) 1992-09-21
EP0504799B1 (de) 1997-07-02
MX9201156A (es) 1992-10-01
IL101257A (en) 1998-03-10
KR100243959B1 (ko) 2000-03-02
HU217809B (hu) 2000-04-28
ES2104758T3 (es) 1997-10-16
HU9200891D0 (en) 1992-05-28
FI921119A (fi) 1992-09-19
FI921119A0 (fi) 1992-03-16
NO921025D0 (no) 1992-03-17
NO178859C (no) 1996-06-19
IL101257A0 (en) 1992-11-15
YU48156B (sh) 1997-05-28
EP0504799A1 (de) 1992-09-23
JP3121428B2 (ja) 2000-12-25
TW199147B (ko) 1993-02-01
FI101701B1 (fi) 1998-08-14
ZA921945B (en) 1992-11-25

Similar Documents

Publication Publication Date Title
DK397785D0 (da) Estere af pyridin-2,4- og -2,5-dicarboxylsyre som laegemidler til inhibering af prolin- og lysinhydroxylase
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
DK0418797T3 (da) Pyrimidin-4,6-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemiddel på basis af disse forbindelser
NO880558D0 (no) Pyridin-2,4- og 2,5-dikarboksylsyreamider, samt fremgangsmaate for fremstilling derav.
DK0590271T3 (da) 17beta-aryl- og 17beta-heterocyclyl-5alfa, 14beta-androstan-, androsten- og -androstadienderivater med aktivitet på det kardiovaskulære system, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
EP0254951A3 (en) Novel 5(and/or 6)substituted 2-(2-imidazolin-2-yl)nicotinic acids, esters and salts, useful as herbicidal agents and novel intermediates for the preparation of said nicotinic acids, esters and salts
DK0641759T3 (da) Anvendelse af aromatiske carboxylsyrederivater til fremstilling af farmaceutiske præparater
ATE46161T1 (de) Verfahren zur herstellung von pyridin-2,3dicarbons|urederivaten und neue 1-amino-1,2,3,4tetrahydropyridin-2,3-dicarbons|urederivate und 1,4-dihydropyridin-2,3-dicarbonsaeurederivate.
NO880556D0 (no) Pyridin-2,4- og 2,5-dikarboksylsyrederivater, samt fremgangsmaater for fremstilling av forbindelsene.
DE69400334D1 (de) Diaminsalze von clavulansäure
DK0504799T3 (da) Blandede pyridin-2,4- og -2,5-dicarboxylsyrediamider, fremgangsmåde til deres fremstilling, deres anvendelse samt lægemidler på basis af disse forbindelser
DK128694A (da) Fremgangsmåde til fremstilling af en 2-(5,5-disubstitueret 4-oxo(eller -thiono)-2-imidazolin-2-yl)-nicotinsyre, -3-quinolincarboxylsyre eller -benzoesyre
ATE117301T1 (de) 2-(1-substituierte-2-imidazolin-2-yl)-benzoe- und nicotinsäuren und verfahren zu deren herstellung.
NO910163L (no) Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid.
DK0584470T3 (da) Fremgangsmåde til fremstilling af 2,3-pyridindicarboxylsyrer ud fra 3-(2-imidazolin-2-yl)-picolinsyrer
SE8301072D0 (sv) 1,4-dihydropyridin-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
DK0548522T3 (da) Fremgangsmåde til rensning af 2,3-pyridin- og -quinolindicarboxylsyrediesterforbindelser